Opzelura Cream
Product Images NDC 50881-007

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Opzelura (NDC 50881-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Incyte Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Opzelura 1)

Chemical structure of ruxolitinib phosphate, the active ingredient in OPZELURA 15 mg/g topical cream, showing the molecular arrangement and functional groups.*

FDA Label Image

Percentage Of Adult And Pediatric Subjects Aged 12 Years And Older With Nonsegmental Vitiligo Achieving F-vasi75 During The 52-week Treatment Period (true V1 And True V2 Combined) (Opzelura 2)

Packaging label for Opzelura (ruxolitinib) cream 1.5%, a topical prescription cream manufactured for Incyte Corporation. The label indicates a 100 g tube with recommended dosage instructions and storage conditions printed on the box. The label includes the NDC 50881-007 and emphasizes topical use only.*

FDA Label Image

Percentage Of Adult And Pediatric Subjects Aged 12 Years And Older With Nonsegmental Vitiligo Achieving T-vasi75 During The 52-week Treatment Period (true V1 And True V2 Combined) (Opzelura 3)

Label for Opzelura (ruxolitinib) cream 1.5%, a topical prescription drug by Incyte Corporation. The label specifies 100 g tube, dosage instructions, active ingredient strength, storage conditions, and manufacturer details, including location in Wilmington, DE. Contains a barcode and NDC 50881-007.*

FDA Label Image

Opzelura (ruxolitinib) Cream 1.5% (100 g Carton Label)

Packaging label for Opzelura (ruxolitinib) cream 1.5%, a topical prescription drug. The carton shows the product name, strength, and form, with directions indicating topical use only. It includes manufacturer details for Incyte Corporation and a 60 g package size. The label also lists recommended dosage instructions and storage conditions.*

FDA Label Image

Opzelura (ruxolitinib) Cream 1.5% (100 g Tube Label)

Label for Opzelura (ruxolitinib) cream 1.5%, a topical prescription drug by Incyte Corporation. The label shows a 60 g tube with directions for topical use only, dosage information, ingredients, storage instructions, and regulatory details including NDC 50881-007. The label includes a barcode and manufacturing location in Wilmington, DE, USA.*

FDA Label Image

Opzelura (ruxolitinib) Cream 1.5% (60 g Carton Label)

The image shows a carton label for Opzelura (ruxolitinib) cream 1.5%, a topical prescription drug by Incyte Corporation. The label specifies a 5 g sample tube, for topical use only, with dosage instructions and storage conditions. The packaging includes the product name, strength, active ingredient, and directions indicating it is Rx only.*

FDA Label Image

Opzelura (ruxolitinib) Cream 1.5% (60 g Tube Label)

Label for Opzelura (ruxolitinib) cream 1.5%, a topical prescription drug. The label indicates a 5 gram sample package, specifying storage conditions between 20°C to 25°C with permitted excursions from 15°C to 30°C. It is manufactured for Incyte Corporation, Wilmington, DE. The label includes sample and temperature details along with branding elements and partial lot/expiration information on the side.*

FDA Label Image

Opzelura (ruxolitinib) Cream 1.5% Sample (5 g Carton Label)

Label for Opzelura (ruxolitinib) cream 1.5%, a topical prescription cream by Incyte Corporation. The label indicates a 5 g sample tube, specifying the concentration as 15 mg/g and listing storage conditions and ingredients on one panel. It includes directions for recommended dosage and usage limitations.*

FDA Label Image

Opzelura (ruxolitinib) Cream 1.5% Sample (5 g Tube Label)

Label for Opzelura (ruxolitinib) cream 1.5%, a topical prescription drug. The label shows a 5 g sample tube with storage instructions, stating to store at 20°C to 25°C (68°F - 77°F) with permitted excursions from 15°C to 30°C (59°F - 86°F). Manufactured for Incyte Corporation, Wilmington, DE, USA.*

FDA Label Image

Opzelura (ruxolitinib) Cream 1.5% Sample (3 g Carton Label)

Label for Opzelura (ruxolitinib) cream 1.5%, a topical prescription drug by Incyte Corporation. The label indicates a 3 g tube sample with the product name, active ingredient, strength, and usage restriction for topical use only. It includes the NDC number 50881-007 and basic storage and handling instructions.*

FDA Label Image

Opzelura (ruxolitinib) Cream 1.5% Sample (3 g Tube Label)

Label for Opzelura (ruxolitinib) cream 1.5%, a topical prescription drug by Incyte Corporation. The label indicates a 3 g sample size, recommended dosage refers to prescribing info, and storage conditions between 20°C-25°C with permitted excursions. Includes the NDC 50881-007-14 and the Incyte logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.